Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests

Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting

Federal policy relating to implementation of anti-kickback requirements in Section 8122 of the Support for Patients and Communities Act, Public Law 115-271

H.R. 6102/S. 3404, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests

The Public Readiness and Emergency Preparedness Act (PREP Act) and COVID-19 liability protection for frontline health care providers, including CLIA-licensed laboratories and their personnel

H.R. 8496, the SPEEDY COVID-19 Tests Act, relating to varying Medicare reimbursement for COVID-19 tests based on result delivery time

Section 307 of H.R. 8406, the Heroes Act, provisions relating to coverage of COVID-19 testing

H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260), and provisions related to clinical laboratory testing for COVID-19, and Medicare reimbursement for pathology services Monitor implementation of H.R. 1865, Further Consolidated Appropriations Act, 2020, (Public Law 116-94) and provisions related to policies regarding data collection from laboratories under the Protecting Access to Medicare Act (PAMA)

S. 2246, Allergy Testing Access Act of 2019, and H.R. 2009, the Removing Barriers to Allergy Diagnostic Tests Act, and provisions relating to Medicare and Medicaid coverage of allergy diagnostic tests

H.R. 1765, the Donald Payne Sr. Colorectal Cancer Detection Act

H.R. 8702/S. 5007, the Holding Providers Harmless from Medicare Cuts During COVID-19 Act National Interest Waiver program for essential workers entering the U.S
HCR - Health Issues MMM - Medicare/Medicaid HOM - Homeland Security
134 - Centers For Disease Control & Prevention (CDC) 135 - Food & Drug Administration (FDA) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 134 - Centers For Disease Control & Prevention (CDC) 135 - Food & Drug Administration (FDA) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 134 - Centers For Disease Control & Prevention (CDC) 135 - Food & Drug Administration (FDA) 201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
QUEST DIAGNOSTICS INCORPORATED
500 Plaza Drive, Secaucus, NJ, 07094, US
SHERRY HARPER WIDICUS SHERRY HARPER WIDICUS SHERRY HARPER WIDICUS